Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial

• Main Authors: Fatemeh Hayati (Author), Heshmatollah Shahbazian (Author), Ali Ghorbani (Author), Shahla Ahmadi Halili (Author), Eisa Rezaei (Author), Leila Sabetnia (Author), Seyed Seifollah Beladi Mousavi (Author)
• Format: Book
• Published: Society of Diabetic Nephropathy Prevention, 2019-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: The current treatment regimens for patients with idiopathic membranous nephropathy (MN) are based on cyclophosphamide-glucocorticoid or calcineurin inhibitor-glucocorticoid. Objectives: We evaluated whether mycophenolate mofetil (MMF) -glucocorticoid could be an option for first-line t...